HYTN Innovations Inc. Stock

Equities

HYTN

CA40443L1040

Non-Alcoholic Beverages

Delayed Canadian Securities Exchange 03:58:39 2024-04-26 pm EDT 5-day change 1st Jan Change
0.32 CAD 0.00% Intraday chart for HYTN Innovations Inc. -15.79% +357.14%
Sales 2022 0.7 0.95 Sales 2023 0.76 1.04 Capitalization 5.3M 7.23M
Net income 2022 -10M -13.65M Net income 2023 -2M -2.73M EV / Sales 2022 8,740,933 x
Net cash position 2022 139K 190K Net Debt 2023 732K 999K EV / Sales 2023 7,897,420 x
P/E ratio 2022
-0.43 x
P/E ratio 2023
-2.27 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 78.56%
More Fundamentals * Assessed data
Dynamic Chart
HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding CI
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
HYTN Innovations Inc. Announces Expansion of 100 MG Nano Shot Citrus to Western Canada CI
HYTN Innovations Inc. announced that it expects to receive CAD 1 million in funding CI
HYTN Innovations Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
HYTN Innovations Inc. announced that it has received CAD 0.505 million in funding CI
HYTN Innovations Inc. announced that it expects to receive CAD 1 million in funding CI
HYTN Innovations Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
HYTN Innovations Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Hytn Innovations Inc. Announces Board Resignations CI
Hytn Innovations Inc. Submits an Amendment to Its Controlled Drugs and Substances Dealers License with Health Canada CI
HYTN Innovations Inc. Expands its Controlled Drugs and Substances Dealers License to Include Mdma and Ketamine CI
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development CI
HYTN Innovations Inc. Auditor Raises 'Going Concern' Doubt CI
More news
1 week-15.79%
Current month+10.34%
1 month+10.34%
3 months+255.56%
6 months+357.14%
Current year+357.14%
More quotes
1 week
0.32
Extreme 0.32
0.39
1 month
0.25
Extreme 0.25
0.39
Current year
0.07
Extreme 0.07
0.39
1 year
0.01
Extreme 0.005
0.39
3 years
0.01
Extreme 0.005
0.47
5 years
0.01
Extreme 0.005
0.47
10 years
0.01
Extreme 0.005
0.47
More quotes
Managers TitleAgeSince
Founder - 90-10-21
Founder - 90-10-21
Director of Finance/CFO 37 21-09-30
Members of the board TitleAgeSince
Director/Board Member 42 22-02-23
Founder - 90-10-21
Founder - 90-10-21
More insiders
Date Price Change Volume
24-04-26 0.32 -11.11% 58,500
24-04-25 0.36 -7.69% 35,075
24-04-24 0.39 +4.00% 11,400
24-04-23 0.375 -1.32% 3,001
24-04-22 0.38 0.00% 16,500

Delayed Quote Canadian Securities Exchange, April 26, 2024 at 03:58 pm EDT

More quotes
HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. The Company formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain 10 milligrams (mg) of THC and are made using its process, Elevation Technology. Its products include Rosewater Lemonade, Watermelon Mint, Lemongrass Ginger, and Blood Orange. Its Rosewater Lemonade is a sugar-free exploration of citrus accented with floral notes. Blood Orange is formulated to bring out the sweet flavors found in this seasonal citrus fruit. Its activities are focused on a single production and manufacturing facility, based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., and 1306562 B.C. Ltd.
Calendar
More about the company